Penn Medicine Neuroscience Center

Press Releases

August 28, 2014
Michael E. Thase, MD, professor of Psychiatry, commented to Reuters Health about a new study which suggests that for about a third of people with depression, adding cognitive therapy to treatment with antidepressant medication helps them reach remission and recovery quicker.
Click for article

August 25, 2014
The Philadelphia Inquirer reports on recent research, led by Daniel Weintraub, MD, associate professor of Psychiatry and Neurology, showing that Parkinson's patients were disproportionately likely to have depression, anxiety, and apathy when diagnosed and throughout the two-year period of the study.
Click for article

August 22, 2014
ALS is a neurodegenerative disease that kills nerve cells in the brain and spinal cord that are responsible for voluntary muscle control. The “ice bucket challenge” has increased awareness and fundraising these past few weeks, but WHYY radio caught up with Leo McCluskey, MD, MBE, medical director of Penn's ALS Center to find out where ALS research stands.
Click for article

The Penn Medicine Neuroscience Center (PMNC) is dedicated to the advancement of the understanding of the brain, spine and peripheral nervous system.

Developing effective treatments and therapies for these areas requires the expertise, dedication and cooperation of scientists from many fields of research.

At Penn, the schools, centers, and institutes across our campus are brought together in the PMNC to create an integrated approach to patient care, education and research.
Learn more about the PMNC

The Co-Directors of the Penn Medicine Neuroscience Center (PMNC) invite you to become a Member of the PMNC.  All faculty at Penn Medicine who work in any neuroscience-related area are welcome to become Members.
Click here for additional information

>Read Articles at Research @ Penn                                         PMNC Newsletter - Spring 2014

Best Hospital